AdipoGen

AdipoGen

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $7M

Overview

AdipoGen is a privately-held, revenue-generating life sciences supplier providing critical research reagents and diagnostic tools to the global scientific community. The company leverages a multi-brand distribution and development model, offering products under its own AdipoGen Life Sciences label as well as from specialized partner brands like Ancell, BellBrook, and RevMAb. Its strategic focus on high-growth research fields like immuno-oncology, metabolism, and innate immunity positions it within the expansive and stable research tools market. While not a therapeutic developer, AdipoGen's commercial success is tied to enabling fundamental and translational research worldwide.

AntibodiesDiagnostics

Technology Platform

Integrated distributor and developer of life science research reagents, including proprietary and multi-brand antibodies, proteins, assay kits, and small molecules, with a focus on validation and niche research areas like inflammasome biology and immunometabolism.

Funding History

2
Total raised:$7M
Series A$5M
Seed$2M

Opportunities

Growth is driven by increasing demand for highly validated research tools in high-funding areas like immuno-oncology and metabolic disease, as well as the trend toward outsourcing specialized reagent development.
The company's multi-brand distribution model allows it to act as a consolidator in a fragmented market.

Risk Factors

Intense competition from large life science conglomerates, dependency on global research funding cycles, and supply chain vulnerabilities for biological materials.
Reputational risk is tied to product performance and the ongoing scientific reproducibility challenge.

Competitive Landscape

AdipoGen competes in a crowded market dominated by giants like Thermo Fisher, Abcam, and Bio-Techne. Its strategy is to compete not on scale but on deep specialization in niche research areas, high-quality validated products, and a curated multi-brand portfolio that offers unique reagents not available from the broad-line majors.